156 related articles for article (PubMed ID: 34906633)
1. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
[TBL] [Abstract][Full Text] [Related]
2. Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.
Park HK; Schildkraut JM; Alberg AJ; Bandera EV; Barnholtz-Sloan JS; Bondy M; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Terry P; Wang F; Ruterbusch JJ; Schwartz AG; Cote ML
Cancer Causes Control; 2018 Nov; 29(11):1081-1091. PubMed ID: 30269307
[TBL] [Abstract][Full Text] [Related]
3. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of serum IL-16 and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Moore A; Huang WY; Danforth K; Falk R; Meade A; Bagni R; Berndt SI
Cancer Causes Control; 2018 May; 29(4-5):455-464. PubMed ID: 29594819
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking and variations in systemic immune and inflammation markers.
Shiels MS; Katki HA; Freedman ND; Purdue MP; Wentzensen N; Trabert B; Kitahara CM; Furr M; Li Y; Kemp TJ; Goedert JJ; Chang CM; Engels EA; Caporaso NE; Pinto LA; Hildesheim A; Chaturvedi AK
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274579
[TBL] [Abstract][Full Text] [Related]
9. Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.
Shikany JM; Flood AP; Kitahara CM; Hsing AW; Meyer TE; Willcox BJ; Redden DT; Ziegler RG
Cancer Causes Control; 2011 Jul; 22(7):995-1002. PubMed ID: 21553078
[TBL] [Abstract][Full Text] [Related]
10. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
[TBL] [Abstract][Full Text] [Related]
11. Pain typology and incident endometriosis.
Schliep KC; Mumford SL; Peterson CM; Chen Z; Johnstone EB; Sharp HT; Stanford JB; Hammoud AO; Sun L; Buck Louis GM
Hum Reprod; 2015 Oct; 30(10):2427-38. PubMed ID: 26269529
[TBL] [Abstract][Full Text] [Related]
12. Risk for colorectal cancer after gynecologic cancer.
Weinberg DS; Newschaffer CJ; Topham A
Ann Intern Med; 1999 Aug; 131(3):189-93. PubMed ID: 10428735
[TBL] [Abstract][Full Text] [Related]
13. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
[TBL] [Abstract][Full Text] [Related]
14. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis.
Borgfeldt C; Andolf E
Acta Obstet Gynecol Scand; 2004 Apr; 83(4):395-400. PubMed ID: 15005789
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive use and benign gynecologic conditions. A review.
Chiaffarino F; Parazzini F; La Vecchia C; Ricci E; Crosignani PG
Contraception; 1998 Jan; 57(1):11-8. PubMed ID: 9554245
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic surgeries for uterine fibroids and ovarian cysts reduce ovarian reserve via age- and surgical type-manner.
Shi X; Chen S; Yang Y; Liu L; Huang L
Gynecol Endocrinol; 2022 Dec; 38(12):1068-1072. PubMed ID: 36198327
[No Abstract] [Full Text] [Related]
18. Prevalence of endometriosis in women undergoing surgery for benign gynecologic diseases.
Tanmahasamut P; Noothong S; Sanga-Areekul N; Silprasit K; Dangrat C
J Med Assoc Thai; 2014 Feb; 97(2):147-52. PubMed ID: 24765891
[TBL] [Abstract][Full Text] [Related]
19. Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.
Prorok PC; Wright P; Riley TR; Kramer BS; Berg CD; Gohagan JK
Rev Recent Clin Trials; 2018; 13(4):257-273. PubMed ID: 29629665
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Wentzensen N; Black A; Jacobs K; Yang HP; Berg CD; Caporaso N; Peters U; Ragard L; Buys SS; Chanock S; Hartge P
PLoS One; 2011; 6(7):e21731. PubMed ID: 21750727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
